[{"id":"2970cc81-805c-417e-8aae-d4e7ccdaa0c2","acronym":"","url":"https://clinicaltrials.gov/study/NCT02587247","created_at":"2021-01-18T12:33:08.299Z","updated_at":"2024-07-02T16:36:06.688Z","phase":"Phase 2","brief_title":"ImmunoTEP With 68-Ga in Metastatic Colo Rectal Cancer","source_id_and_acronym":"NCT02587247","lead_sponsor":"Nantes University Hospital","biomarkers":" CEACAM5","pipe":" | ","alterations":" CEACAM5 expression • CEACAM5 positive","tags":["CEACAM5"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CEACAM5 expression • CEACAM5 positive"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e TF2"],"overall_status":"Completed","enrollment":" Enrollment 11","initiation":"Initiation: 03/01/2016","start_date":" 03/01/2016","primary_txt":" Primary completion: 01/01/2017","primary_completion_date":" 01/01/2017","study_txt":" Completion: 01/01/2017","study_completion_date":" 01/01/2017","last_update_posted":"2022-07-26"},{"id":"9508dcc2-62aa-4230-82cb-15f76f0bee0b","acronym":"iTEPsein","url":"https://clinicaltrials.gov/study/NCT01730612","created_at":"2021-01-18T07:33:33.710Z","updated_at":"2024-07-02T16:37:08.547Z","phase":"Phase 1/2","brief_title":"ImmunoTEP au 68-Ga- IMP-288 for Patients With a Recurrence of HER2 Negative Breast Carcinoma Expressing CEA","source_id_and_acronym":"NCT01730612 - iTEPsein","lead_sponsor":"Nantes University Hospital","biomarkers":" HER-2","pipe":"","alterations":" ","tags":["HER-2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e TF2"],"overall_status":"Completed","enrollment":" Enrollment 23","initiation":"Initiation: 12/01/2012","start_date":" 12/01/2012","primary_txt":" Primary completion: 05/01/2017","primary_completion_date":" 05/01/2017","study_txt":" Completion: 05/01/2017","study_completion_date":" 05/01/2017","last_update_posted":"2018-07-27"},{"id":"96ed0478-102e-4b80-9602-ad596e7b15a8","acronym":"","url":"https://clinicaltrials.gov/study/NCT01221675","created_at":"2021-01-18T04:54:28.690Z","updated_at":"2024-07-02T16:37:29.423Z","phase":"Phase 1/2","brief_title":"TF2- Small Cell Lung Cancer Radio Immunotherapy","source_id_and_acronym":"NCT01221675","lead_sponsor":"Centre René Gauducheau","biomarkers":" EGFR","pipe":" | ","alterations":" EGFR mutation • CEACAM5 positive","tags":["EGFR"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e EGFR mutation • CEACAM5 positive"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e TF2"],"overall_status":"Completed","enrollment":" Enrollment 18","initiation":"Initiation: 06/01/2011","start_date":" 06/01/2011","primary_txt":" Primary completion: 04/01/2016","primary_completion_date":" 04/01/2016","study_txt":" Completion: 04/01/2016","study_completion_date":" 04/01/2016","last_update_posted":"2016-08-31"}]